Chinese Classics recitation training for people with subjective memory concerns
Official title: The Effect of Memory Training by Chinese Classics Recitation on Individuals With Subjective Cognitive Decline
Run by China Medical University Hospital · NCT07463391 · Data updated 2026-11-12
A 6-month program of Chinese Classics recitation is being tested to see if it helps people aged 60+ who notice memory problems but don’t have measurable impairment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | China Medical University Hospital Academic / other |
| Locations | 1 site (Taichung) |
| Status | Recruiting |
| Started | August 1, 2026 |
| Main results expected | July 31, 2029 |
| Study ends | December 31, 2032 |
| Registry record updated | October 22, 2026 |
| Trial ID | NCT07463391 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 60 or older with self-reported memory concerns but no objective cognitive impairment or dementia.
✕Probably not a fit
Individuals with objective cognitive impairment, MCI, or dementia, or with significant psychiatric or medical conditions that could explain memory problems, may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, assessor-blinded trial will enroll 60 adults 60 years or older with subjective cognitive decline and randomly assign them to the recitation training or a non-active control for six months. Participants will undergo neuropsychological testing, plus multimodal brain and biological assessments (fMRI, EEG, blood biomarkers, gut microbiota, and fecal metabolomics) at baseline, after the intervention, and during annual follow-ups. The goal is to understand potential brain and biological changes associated with this culturally tailored memory-training approach. Results will help determine whether this training can slow or alter early cognitive concerns and what biomarkers may reflect any effects.
Why it matters
Potential benefit: If successful, participants may experience improvements in memory-related performance and associated brain function.
How similar studies have gone: Previous studies in cognitive training show potential, but responses vary; this approach adds a culturally tailored intervention with multimodal assessments to explore novelty and effectiveness.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 60 years old * At least two "yes" responses to the following questions are required: 1. Forgetting where things are placed? 2. Unable to recall the names of good friends? 3. Unable to follow and recall conversation? 4. Subjective memory problems? 5. Consider own memory to be worse than others of a similar age? Exclusion Criteria: * Objective cognitive impairment defined as ≥ 1.5 standard deviations below standardized cognitive testing (e.g., MMSE) * Diagnosis of MCI * Clinical Dementia Rating (CDR) ≥ 0.5 * Diagnosis of major depressive disorder * Beck Anxiety Inventory score ≥ 16 * Other medical or neurological conditions that could explain cognitive decline (e.g., vascular dementia, traumatic brain injury) * Claustrophobia * Contraindications of MRI (e.g., non-MRI-compatible cardiac pacemaker or devices implanted within the past three months)
Where it's running
-
China Medical University Hospital
Taichung, Taiwan Recruiting
Study contacts
- Study coordinator: Sheng-Ta Tsai, M.D., Ph.D.
- Email: tshengdar@gmail.com
- Phone: 886-928262460
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Daily-life Virtual Reality Training to Support Thinking and Daily Tasks in adults 50 and older
A touchscreen-based daily-life VR program is being tested to see if it helps people 50+ improve daily activities and thinking skills, especially for those at risk of dementia.
-
Aging Brain Health Initiative in Fujian
This observational study will follow about 3,000 older adults in Fujian to see how Alzheimer's-related changes develop and to test new digital tests, biomarkers, and imaging tools for early diagnosis.
-
Longitudinal profiling of plasma-derived glial extracellular vesicles in Alzheimer's disease
This study tests whether plasma glial extracellular vesicles and neuroinflammation biomarkers change over time across the Alzheimer’s disease spectrum and whether these signals relate to amyloid, tau, and neurodegeneration, with an additional step of exposing healthy iPSC-derived neurons to vesicles to see potential ne
-
Digital tools to predict Alzheimer's biology from risk factors
This study tests a digital, AI-based tool that analyzes modifiable and non-modifiable risk factors to see if it can predict biological changes linked to Alzheimer's disease in adults with MCI or SCD.
-
Blood tests using plasma biomarkers to diagnose and track Alzheimer’s disease
A large, year-long study in Milan is testing whether blood markers can help diagnose Alzheimer’s and predict how it will progress in people with memory concerns.
-
Personalized Brain Health Service for Dementia Prevention in People with Subjective Cognitive Decline
This study tests a personalized Brain Health Service to see if tailored risk assessment and a 6‑month lifestyle program can lower dementia risk for people aged 55–85 who have subjective cognitive concerns.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.